E8.1 Methods for the assessment of variant pathogenicity in cardiac diseases

• Date : 2016-05-21
• 4    
  0

E3.1Induced pluripotent stem cell-based studies, challenges and promises

• Date : 2016-05-21
• 2    
  0

E7.2 Opportunities for Scaling Up Genetic Analysis

• Date : 2016-05-21
• 2    
  0

E1-1 Long-read sequencing of complex genomes

• Date : 2016-05-21
• 1    
  0

E2.2 Genetic Privacy and Data Sharing

• Date : 2016-05-21
• 1    
  0

E1.2 Nanopore sequencing

• Date : 2016-05-21
• 1    
  0

E2.1 The hitchhiker's guide to genome hacking

• Date : 2016-05-21
• 1    
  0

E3.2 Direct reprogramming for studies of aging and neurodegeneration

• Date : 2016-05-21
• 1    
  0

E4.2 The value of phenotypic assays in peroxisomal disorders

• Date : 2016-05-21
• 1    
  0

E5.1 Cilia in human developmental anomalies

• Date : 2016-05-21
• 1    
  0

E5.2 expanding Ciliopathies

• Date : 2016-05-21
• 1    
  0

E6.1 Cost-effectivness of diagnostics in rare diseases

• Date : 2016-05-21
• 1    
  0

E6.2 Cost-effectivness of testing in cancer

• Date : 2016-05-21
• 1    
  0

E7.1 Removing "unwanted variation" in sequence data

• Date : 2016-05-21
• 1    
  0

E8.2 The ACMGG recommendations for the interpretation of genetic variants

• Date : 2016-05-21
• 1    
  0

13ème Assises de Génétiques Humaine et Médicale 2025

• Date : 2026-01-27
• 764    
  0

ASHG Conférence Annuelle 2025

• Date : 2025-10-14
• 1416    
  0

28ème Congrès annuel de l'American Society of Gene & Cell Therapy - ASGCT 2025

• Date : 2025-05-13
• 1007    
  0

51ème Congrès Annule de l'EBMT

• Date : 2025-03-30
• 1097    
  0

Empowering patients 2025 : un sommet de l'American Society of Gene and Cell Therapies – ASGCT 2025

• Date : 2025-03-12
• 753    
  0